To further investigate MYC regulation in ALK+ NSCLC, we examined the expression of MYC and MYCBP in response to pharmacologic ALK inhibition in ALK+ NSCLC cell lines. This evidence concerns the gene MYCBP and non-small cell lung carcinoma.